Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12F6A | ISIN: US87265T1034 | Ticker-Symbol:
Branche
Telekom
Aktienmarkt
Sonstige
1-Jahres-Chart
TPT GLOBAL TECH INC Chart 1 Jahr
5-Tage-Chart
TPT GLOBAL TECH INC 5-Tage-Chart
ACCESSWIRE
441 Leser
Artikel bewerten:
(2)

TPT Global Tech, Inc.: TPT Global Tech's Subsidiary Completes Merger to Tap Into "Culture is the New Technology"

A Global Marketplace Vision by Urban Icon

SAN DIEGO, CA / ACCESSWIRE / July 25, 2024 / TPT Global Tech (OTC Pink:TPTW) announces today that its subsidiary, TPT Strategic (INOQ), has entered into a strategic merger acquisition with Urban Icon (UI), a Holding Company acquiring FutureTech companies that understand the power of social impact, technological and cultural innovation.

UI's general mandate crosses multiple industries including Fintech, Electric Mobility, AI and Blockchain driven products, including a Global 360 Health Initiative (physical, mental, environmental, and finance health) that supports the social and economic growth of the New Urban markets. The Company has already identified several investment opportunities and has executed several LOI's with strong leadership teams, assets, and revenue strategies.

As part of the merger, the stock symbol will change from INOQ to NURB (NewUrban). Urban Icon Holdings will gain a majority interest, while TPT Global will hold a minority position in the new offering.

In addition, the merger gives TPT access to Urban Icon's social media and entertainment market expertise to assist in the development, partnerships and marketing of the VüMe super app. This integration aims to enhance VüMe's capabilities, offering a comprehensive range of services and solutions across various industries, thus expanding its user base and increasing its societal impact while driving revenue for both companies on a global scale.

"We are thrilled to merge TPT Strategic with Urban Icon, which shares our vision of driving social impact through technological innovation," said Stephen J. Thomas III, CEO of TPT Global Tech. "This merger not only broadens our technological capabilities but also reinforces our commitment to supporting diverse entrepreneurs and integrating impactful tech solutions into our VüMe super app and at the same time increasing our technology IP and shareholders' equity".

For more information or details on the TPT Strategic and Urban Icon strategic Merger acquisition individuals can go to the TPT Global tech's 8k filing with SEC or TPT Global Tech website.

About Urban Icon Int'l Holdings :

"Culture is the New Technology" is the ongoing mantra and values proposition of the Company. UI's Board of Directors and Executive Team are leveraging over 100 combined years of experience in the top positions and categories surrounding entertainment, lifestyle and culture, banking, and personal tech.

The Company will also launch its long awaited Venture Studio by the 1st Quarter 2025 funding at least 7 to 10 investment deals per year. UI is positioned to operate in Los Angeles & London over the next year and has interests in the Middle East and Africa.

About TPT Global Tech

TPT Global Tech, Inc. is a technology holding company based in San Diego, California. It was formed as the successor of two U.S. corporations, Ally Pharma US and TPT Global, Inc. The Company operates in various sectors including media, telecommunications, Smart City Real Estate Development, and the launch of the first super App, VüMe Live technology platform.

As a media content delivery hub, TPT Global Tech utilizes its own proprietary global digital media TV and telecommunications infrastructure platform. They offer software as a service (SaaS), technology platform as a service (PAAS), and cloud-based unified communication as a service (UCaaS) solutions to businesses worldwide. Their UCaaS services enable businesses of all sizes to access the latest voice, data, media, and collaboration features.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.

For more information about TPT Global Tech and its subsidiaries, please visit www.tptglobaltech.com.

For media or Investment inquiries, please contact: Rick@tptglobaltech.com

SOURCE: TPT Global Tech, Inc.



View the original press release on accesswire.com

© 2024 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.